This MALT1-TGF-β-NF-κB axis explains TGF-β’s dual role in cancer progression, contributing to survival, proliferation, and metastasis of cancer cells, and highlights MALT1 as a potential therapeutic target for disrupting this interaction in cancer treatment [48]. Here, NFKB1 is linked to cancer.